Text

Japanese gut metagenomes show microbial features associated with diet and disease

The findings of a japanese research suggest that several viruses are linked to specific populations and diseases.

Gut microbes may mediate beneficial effects of low-carb diet on irritable bowel syndrome

Researchers have found that a diet low in fermentable carbohydrates can alter the human microbiota in ways that influence the expression of genes involved in inflammation and intestinal integrity.

MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program

With the achievement of this new milestone, both companies will now advance this research which focuses on developing innovative therapies for metabolic diseases.

Novozymes and Chr. Hansen to merge and create a leading global biosolutions partner

The new group will have annual revenues of approximately 3.5 billion euros ($3.7 billion), the companies said.

How the tumor microbiota may reduce the efficacy of cancer drugs

A recent study confirms that 5-FU exerts part of its anti-cancer effects through inhibiting the growth of F. nucleatum, the commensal associated with colorectal cancer progression.

Federation Bio Administers First Dose in Phase 1 Clinical Trial Evaluating Investigational Bacterial Cell Therapy

FB-001 is a rationally designed consortium of 148 defined bacterial strains with unprecedented diversity, representing a complete microbiome replacement

A closer look at the microbiota of the small intestine

A recent study confirms that ileum and colon have a distinct microbiota: unlike the bacterial composition of the colon, the ileum is subject to frequent fluctuations.

Gut bacteria influence response to cocaine in mice

The findings of a new research may help to inform therapies to modulate brain circuits that are involved in substance use disorders.

COVID-19 may disrupt gut microbiota to increase risk for other infections

Microbiota alterations in COVID-19 patients appeared to be associated with secondary infections of the blood by gut bacteria: four cases of positive blood cultures of Staphylococcus species were identified.

FDA Approves First Fecal Microbiota Product

Rebyota Approved for the Prevention of Recurrence of Clostridioides difficile Infection in Adults

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.